Supraventricular Tachycardia - Medications for Infants (SAIMIS Trial)
A Randomized Multi-Centered Study of Anti-Arrhythmic Medications in the Treatment of Infants with Supraventricular Tachycardia (SAIMIS Trial)
Protocol ID
06-080
Protocol Description
An episode of rapid heart beat called supraventricular tachycardia (SVT) is the most common type of fast heart beat in infants. The purpose of this research study is to determine whether propranolol or digoxin is more effective at preventing recurrences of SVT in infants.
Eligibility Criteria
Infants who have experienced supraventricular tachycardia (SVT)
Primary Investigator(s)
- Andrew Blaufox, MD